1. Home
  2. NSPR vs XBP Comparison

NSPR vs XBP Comparison

Compare NSPR & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

BUY

Current Price

$0.46

Market Cap

38.9M

Sector

Health Care

ML Signal

BUY

Logo XBP Europe Holdings Inc.

XBP

XBP Europe Holdings Inc.

SELL

Current Price

$2.96

Market Cap

41.3M

ML Signal

SELL

Company Overview

Basic Information
Metric
NSPR
XBP
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
41.3M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
NSPR
XBP
Price
$0.46
$2.96
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
★ 108.5K
14.1K
Earning Date
11-03-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 183.67
EPS
★ N/A
N/A
Revenue
$2,310,000.00
★ $872,690,000.00
Revenue This Year
$9.14
$2.47
Revenue Next Year
$105.44
$10.86
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.46
$0.41
52 Week High
$2.41
$8.55

Technical Indicators

Market Signals
Indicator
NSPR
XBP
Relative Strength Index (RSI) 24.56 43.43
Support Level N/A $2.75
Resistance Level $1.00 $3.00
Average True Range (ATR) 0.08 0.13
MACD -0.01 -0.03
Stochastic Oscillator 2.19 24.75

Price Performance

Historical Comparison
NSPR
XBP

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.

Share on Social Networks: